Pharming Group
PHAR
2 hedge funds and large institutions have $2.96M invested in Pharming Group in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$29M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JAM
1
JW Asset Management
Miami Beach,
Florida
| $2.95M | +$29M | +1,895,941 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $14K | +$14K | +916 | New |
|
PHAR Hedge Fund Activity: Q4 2020 in Review
2 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q4 2020, worth a combined $2.96M.
Buyers outnumbered sellers: 2 funds opened new PHAR positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was JW Asset Management, opening a new position worth an estimated $29M.
- 2 institutional investors held Pharming Group (PHAR) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $2.96M of Pharming Group stock for Q4 2020.
- 2 funds opened new Pharming Group positions in Q4 2020 and 0 closed out, a net change of +2 holders.
- The largest Pharming Group buyer in Q4 2020 was JW Asset Management, an estimated $29M added.
Based on aggregated 13F filings for Q4 2020.